Instructions for Betahistine tablets
English product name
Betahistine
Release Form
tab. 8 mg: 10, 20, 30, 40, 50, 60, 80 or 100 pcs.
tab. 16 mg: 10, 20, 30, 40, 50, 60, 80 or 100 pcs
Description
Tablets 1 tab.
betagistine dihydrochloride 16 mg
ATC codes
N07CA01 Betahistine
Clinical-pharmacological groups / Group affiliation
Agent for improving labyrinth microcirculation used for pathology of the vestibular apparatus
Active substance
betagistine dihydrochloride
Pharmaco-therapeutic group
Histamine preparation
Storage Conditions
In a dry, light-proof place at a temperature not higher than 25°C. Store in a place not accessible to children.
Best before date
The shelf life is
Pharmacological effect Betahistine
Histamine drug
Betagistin acts mainly on histamine H1 and H3 receptors of the inner ear and vestibular nuclei of the central nervous system. By direct agonistic action on the H1 receptors of the inner ear vessels, as well as indirectly on the H3 histamine receptors of the vestibular, central nervous system (CNS) nuclei, it improves the microcirculation and permeability of capillaries, normalizes endolymph pressure in the labyrinth and snail. However, betagistin increases blood flow in the basilar artery.
Testimony Betahistine
- Treatment of Ménière syndrome, characterized by dizziness (accompanied by nausea and vomiting), reduced hearing and tinnitus,
- symptomatic treatment of vestibular vertigo.
Method of use and doses Betahistine
Inside, while eating.
8 mg tablets: 1-2 tablets three times a day.
16 mg tablets: 1/2-1 tablet three times a day.
The improvement is usually observed at the beginning of therapy, the stable therapeutic effect occurs after two weeks of treatment and may increase during several months of treatment.
